ArticleFrontiers in oncology2025

Safety and efficacy of apatinib in combination treatment versus apatinib as second-line treatment for advanced gastric cancer.

Zhang Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.